To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
6 Current news of Integra Communications
rss09-11-2012
BioCity Nottingham is ten years old this November. When Boots/BASF vacated their research and development facility in 2002 around 500 highly-specialised scientific jobs were lost. Now BioCity, in the newly-formed Creative Quarter of Nottingham, provides a base for 74 early-stage and growing ...
31-08-2012
BioCity Scotland has announced the appointment of Dr Allison Jeynes-Ellis MB ChB, FFPM as a new Board member. Formerly Medical and Innovation Director with the Association of British Pharmaceutical Industry, Dr Jeynes-Ellis will assume the position in September 2012.Over twenty years industry ...
06-07-2012
Fraser Black, former Global Services Solutions Director with GE Life Sciences has been appointed as Managing Director of BioCity Scotland, the centre for life science businesses in Newhouse, Lanarkshire. He takes over from Ian Webster, acting Managing Director since the organisation’s launch ...
06-06-2012
Medilink East Midlands has been named as the UK partner for Biomat-IN, the newly established €1.24 million biomaterials innovation network which spans the UK, France, Germany and the Netherlands. With biomaterials now being used in many medical applications - such as dental restoration, heart ...
18-05-2012
Sygnature Discovery Limited and Pneumolabs (UK) Limited announced they have entered into a strategic alliance. Under the terms of the agreement, Sygnature and Pneumolabs will collaborate to provide a fully-integrated drug discovery service to accelerate clients’ drug discovery programmes ...
24-11-2011
New Chairman of BioCity Nottingham Louis J Nisbet DSc PhD assumes his position this month amidst significant changes and challenges in the global life sciences sector.With increasing fragmentation in the drug discovery industry and the dramatic reduction in government-funded support for ...


